KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Net Margin (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Net Margin for 11 consecutive years, with 19.07% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 273.0% year-over-year to 19.07%, compared with a TTM value of 63.68% through Dec 2025, up 4450.0%, and an annual FY2025 reading of 17.83%, down 134.0% over the prior year.
  • Net Margin was 19.07% for Q4 2025 at Medpace Holdings, down from 21.81% in the prior quarter.
  • Across five years, Net Margin topped out at 21.81% in Q4 2024 and bottomed at 13.25% in Q2 2023.
  • Average Net Margin over 5 years is 16.84%, with a median of 16.73% recorded in 2024.
  • The sharpest move saw Net Margin plummeted -485bps in 2021, then soared 610bps in 2024.
  • Year by year, Net Margin stood at 16.22% in 2021, then rose by 7bps to 17.42% in 2022, then decreased by -10bps to 15.71% in 2023, then surged by 39bps to 21.81% in 2024, then fell by -13bps to 19.07% in 2025.
  • Business Quant data shows Net Margin for MEDP at 19.07% in Q4 2025, 21.81% in Q4 2024, and 18.08% in Q3 2024.